4//SEC Filing
Martin Christopher Nathan 4
Accession 0000907654-25-000019
CIK 0000907654other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 4:41 PM ET
Size
5.5 KB
Accession
0000907654-25-000019
Insider Transaction Report
Form 4
Martin Christopher Nathan
Director
Transactions
- Award
Stock Option (right to buy)
2025-12-11+35,000→ 35,000 totalExercise: $30.21Exp: 2035-12-10→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/36 of the underlying shares monthly from December 11, 2025.
Issuer
Oruka Therapeutics, Inc.
CIK 0000907654
Entity typeother
Related Parties
1- filerCIK 0002097992
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 4:41 PM ET
- Size
- 5.5 KB